Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/50559
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Torres, Fernando | en_US |
dc.contributor.author | Quintana, José | en_US |
dc.contributor.author | Estévez, Francisco | en_US |
dc.contributor.other | Quintana, Jose | - |
dc.contributor.other | Estevez, Francisco | - |
dc.contributor.other | Torres Andon, Fernando | - |
dc.date.accessioned | 2018-11-24T16:59:34Z | - |
dc.date.available | 2018-11-24T16:59:34Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.issn | 0899-1987 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/50559 | - |
dc.description.abstract | Flavonoids are polyphenolic compounds which display a vast array of biological activities and are promising anticancer agents. In this study we investigated the effect of 5,7,3′-trihydroxy-3,4′-dimethoxyflavone (THDF) on viability of nine human tumor cell lines and found that it was highly cytotoxic against leukemia cells. THDF induced G2-M phase cell-cycle arrest and apoptosis through a caspase-dependent mechanism involving cytochrome c release, processing of multiple caspases (caspase-3, -6, -7, and -9) and cleavage of poly(ADP-ribose) polymerase. Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-xL conferred partial resistance to THDF-induced apoptosis. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases (MAPKs) family and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) and of extracellular signal-regulated kinases (ERK) 1/2. In the present study we report that THDF-induced cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. The results suggest that THDF could be useful in the development of novel anticancer agents. | en_US |
dc.language | eng | en_US |
dc.relation | Desarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicos | en_US |
dc.relation | Evaluación de Tdf Como Potencial Fármaco Antitumoral. | en_US |
dc.relation.ispartof | Molecular Carcinogenesis | en_US |
dc.source | Molecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 (Mayo 2010) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320703 Carcinogénesis | en_US |
dc.subject.other | G(2)-M Phase Arrest | en_US |
dc.subject.other | Differential Regulation | en_US |
dc.subject.other | Signal-Transduction | en_US |
dc.subject.other | Induced Apoptosis | en_US |
dc.subject.other | Mammalian-Cells | en_US |
dc.subject.other | Cancer Cells | en_US |
dc.subject.other | Jnk | en_US |
dc.subject.other | Quercetin | en_US |
dc.subject.other | Kinase | en_US |
dc.subject.other | Inhibition | en_US |
dc.title | 5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1002/mc.20619 | en_US |
dc.identifier.scopus | 77953033838 | - |
dc.identifier.isi | 000277311800004 | - |
dcterms.isPartOf | Molecular Carcinogenesis | - |
dcterms.source | Molecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 | - |
dc.contributor.authorscopusid | 55366045300 | - |
dc.contributor.authorscopusid | 8681043500 | - |
dc.contributor.authorscopusid | 7003810011 | - |
dc.description.lastpage | 475 | en_US |
dc.identifier.issue | 5 | - |
dc.description.firstpage | 464 | en_US |
dc.relation.volume | 49 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.wos | WOS:000277311800004 | - |
dc.contributor.daisngid | 34941095 | - |
dc.contributor.daisngid | 2952604 | - |
dc.contributor.daisngid | 128315 | - |
dc.contributor.daisngid | 384944 | - |
dc.identifier.investigatorRID | K-5709-2014 | - |
dc.identifier.investigatorRID | K-5125-2014 | - |
dc.identifier.investigatorRID | D-5184-2009 | - |
dc.description.numberofpages | 12 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Torres, F | - |
dc.contributor.wosstandard | WOS:Quintana, J | - |
dc.contributor.wosstandard | WOS:Estevez, F | - |
dc.date.coverdate | Mayo 2010 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.jcr | 3,265 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.project.principalinvestigator | Estévez Rosas, Francisco Jesús | - |
crisitem.project.principalinvestigator | Quintana Aguiar, José Martín | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0001-8225-4538 | - |
crisitem.author.orcid | 0000-0002-9728-2774 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Quintana Aguiar, José Martín | - |
crisitem.author.fullName | Estévez Rosas, Francisco Jesús | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.